Benchmark Investment Advisors LLC Moderna, Inc. Transaction History

Benchmark Investment Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $219,618 - $331,106	-1,875 Reduced 34.43%	3,571 $510,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $48,434 - $90,024	383 Added 7.56%	5,446 $938,000
Q4 2021 Feb 16, 2022	BUY	$225.82 - $368.51 $1.14 Million - $1.87 Million	5,063 New	5,063 $1.29 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Benchmark Investment Advisors LLC with notifications on news.